Insider trades

Christopher M. Starr, Director of Monopar Therapeutics MNPR, has filed 0 purchases and 1 sale on the open market. The latest trade was on 25/12/02.

Christopher M. Starr

Director
First filing
23/01/03
Trades
17 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
25/12/02

Trading activity

Transactions

Trade type
Open-market sale25/07/1425/07/1616,800 sh$40.00$672,000−76.5%